Results

Total Results: 2,902 records

Showing results for "medications".
Users also searched for: medication reconciliation

281. Kravitz_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/kravitz_eccs2012.pdf
     January 01, 2012 - expectations for care after their visits. o Most, but not all, of the unmet expectations concerned medications … • Patients may seem  to want medications when they actually want information, reassurance, or commitment

282. Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage Renal Disease (ESRD) | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-disease-anemia/abstract
     March 31, 2011 - varying nature of iron administration as well as confounders of iron administration (e.g. use of other medications

283. Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-illness-heart/research
     April 22, 2013 - 1.68), the anticonvulsive medications topiramate and zonisamide (MD ?5.11kg; CI, ?9.48 to ?

284. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
     January 01, 2008 - What types of individuals continue to require ocular or glaucoma medications after surgery? 3.

285. CER 5 Renal Artery Stenosis NSD SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
     June 24, 2014 - improved or worse outcomes of renal artery angioplasty with stent placement, including periprocedural medications

286. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
     February 01, 2015 - National Institute on Aging, approved AD medications treat disease symptoms only, including progressive … These medications do not change the underlying disease process. … intranasal insulin could improve patient health improvements while providing cost savings over other AD medications … limited in scope and did not sufficiently validate intranasal insulin as superior to approved AD medications … Even if prescribed as an adjunct to other medications, experts 5 remarked, any additional cost

287. Medical Management of Kidney Stones (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-key-questions.pdf
     July 03, 2023 - (both targeted and empiric) and/or pharmacological treatment, including over-the-counter (OTC) medications … (Dietary and/or pharmacological treatment, including over-the-counter (OTC) medications or supplements … Dietary (both targeted and empiric) and/or pharmacological treatment, including over- the-counter (OTC) medications … treatment (targeted and empiric) and/or pharmacological treatment, including over-the-counter (OTC) medications … (both targeted and empiric) and/or pharmacological treatment, including over-the-counter (OTC) medications

288. Reducing Hospital Length of Stay Supplemental Info (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nom-length-stay-supplement.pdf
     June 27, 2019 - strategies may include: • Clinical care approaches to reducing LOS (e.g., switching from IV to oral medications

289. Screening for and Management of Chronic Kidney Disease Stages 1-3 | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
     July 28, 2010 - artery bypass, ace-inhibitors (ACEI), beta-blockers, or HMG CoA-reductase inhibitors (i.e., statins) medications … Food & Drug Administration (FDA) status, indications, and warnings for these medications are included … blockers (ARB) ACEI/ARB combination Aldosterone antagonists Other classes of antihypertensive medications … diuretics, thiazide diuretics, alpha blockers) Glycemic control Individual classes of diabetes medications … sulfonylureas, thiazolidinediones, biguanides) Lipid control Individual classes of lipid control medications

290. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
     November 01, 2010 - artery bypass, ace-inhibitors (ACEI), beta-blockers, or HMG CoA-reductase inhibitors (i.e., statins) medications … review will consider the impact on clinical outcomes in CKD patients of treatment with individual medications … Food & Drug Administration (FDA) status, indications, and warnings for these medications are included … diuretics, thiazide diuretics, alpha blockers) • Glycemic control • Individual classes of diabetes medications … other (including different dose levels, tight control vs. less tight control, and combinations of medications

291. Interventions Addressing Children Exposed to Trauma: Part 2 – Trauma Other Than Child Maltreatment and Family Violence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/trauma-child-interventions/research-protocol
     March 26, 2012 - Other medications . … These medications are thought to work through various mechanisms. … Because PTSD often causes hyperarousal and associated physiologic changes, medications that treat these … These medications include risperidone and quetiapine. … Medications in this class include clonazepam, diazepam, alprazolam, and lorazepam.

292. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/trauma-child-interventions_research-protocol.pdf
     March 26, 2012 - Other medications that target physiologic hyperarousal and memory consolidation may also be used to … Other medications. … These medications are thought to work through various mechanisms. … These medications include risperidone and quetiapine. … Medications in this class include clonazepam, diazepam, alprazolam, and lorazepam.

293. Immune System and Disorders | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/immune-system-and-disorders
     July 16, 2013 - Rhinoconjunctivitis and/or Asthma Research Protocol Archived August 24, 2011 ADHD Medications

294. Impact of Employment Interventions for Persons with Serious Mental Illnesses (SMI) on Non-Employment Patient-Centered Outcomes | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/mental-illness-employment/abstract
     December 20, 2011 - and 30 days of hospital discharge; (2) Coordination and continuity of care, including continuity of medications

295. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/20.html
     June 08, 2018 - The medications needed to treat some of these conditions also have side effects.    

296. Wireless Motility Capsule Versus Other Diagnostic Technologies for Evaluating Gastroparesis and Constipation: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/wireless-motility-capsule/research-protocol
     March 14, 2012 - Delay of gastric emptying is commonly caused by the use of certain medications such as narcotics or glucagon-like … Most radiology centers require that all possible interfering medications such as narcotics, motility … Other outcomes include the ability of testing to influence treatment decisions by changes in medications … Other outcomes include the ability of testing to influence treatment decisions such as change in medications … Motility assessment Transit time Pressure patterns Treatment decisions Change in medications

297. Comparative Effectiveness of Second Generation Antidepressants in the Pharmacologic Treatment of Adult Depression – An Update to a 2007 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antidepressants-update/research-protocol
     July 13, 2011 - In general, the efficacy of first- and second-generation antidepressant medications is similar (Mulrow … patients find intolerable, and the risk for harm when taken in overdose or in combination with certain medications … symptoms such as anxiety, insomnia, and neurovegetative symptoms, do mediations or combinations of medications … These medications with new formulations (such as an extended release formulation) are approved by the … The new sub-question would explore the comparative efficacy of immediate and extended release medications

298. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
     May 19, 2010 - high-quality evidence overall to reach conclusions about the efficacy of any off-label indications of these medications … Sub-Question 2: How do atypical antipsychotic medications compare with other drugs, including first … Adverse events associated with on-label use of the atypical antipsychotic medications will be summarized … grouped together due to their difference from the group of conventional, or typical, antipsychotic medications … We will also summarize adverse events associated with on-label use of the atypical antipsychotic medications

299. Efficacy and Comparative Effectiveness of Off-Label Use of Atypical Antipsychotics – Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atypical-antipsychotics-off-label-update/research-protocol
     May 19, 2010 - high-quality evidence overall to reach conclusions about the efficacy of any off-label indications of these medications … Sub-Question 2: How do atypical antipsychotic medications compare with other drugs, including first … Adverse events associated with on-label use of the atypical antipsychotic medications will be summarized … grouped together due to their difference from the group of conventional, or typical, antipsychotic medications … We will also summarize adverse events associated with on-label use of the atypical antipsychotic medications

300. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
     July 13, 2011 - In general, the efficacy of first- and second-generation antidepressant medications is similar (Mulrow … patients find intolerable, and the risk for harm when taken in overdose or in combination with certain medications … symptoms such as anxiety, insomnia, and neurovegetative symptoms, do mediations or combinations of medications … These medications with new formulations (such as an extended release formulation) are approved by the … The new sub-question would explore the comparative efficacy of immediate and extended release medications